Production of resistant HIV mutants during antiretroviral therapy (Q4488644): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q35165357, #quickstatements; #temporary_batch_1710286856230 |
ReferenceBot (talk | contribs) Changed an Item |
||
| (One intermediate revision by one other user not shown) | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1073/pnas.97.14.7681 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2060701294 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: The concept of <i>R<sub>o</sub></i> in epidemic theory / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Drug concentration heterogeneity facilitates the evolution of drug resistance / rank | |||
Normal rank | |||
Latest revision as of 10:32, 30 May 2024
scientific article; zbMATH DE number 1471292
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Production of resistant HIV mutants during antiretroviral therapy |
scientific article; zbMATH DE number 1471292 |
Statements
Production of resistant HIV mutants during antiretroviral therapy (English)
0 references
17 March 2001
0 references
multistrain models
0 references
HIV drug therapy
0 references
multidrug resistance
0 references
